Arcturus Therapeutics Holdings (ARCT) Gains from Investment Securities: 2018-2024
Historic Gains from Investment Securities for Arcturus Therapeutics Holdings (ARCT) over the last 2 years, with Dec 2024 value amounting to $564,000.
- Arcturus Therapeutics Holdings' Gains from Investment Securities fell 88.25% to $564,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $7.6 million, marking a year-over-year decrease of 77.97%. This contributed to the annual value of $8.1 million for FY2024, which is 1.35% up from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Gains from Investment Securities stood at $564,000 for Q4 2024, which was down 79.39% from $2.7 million recorded in Q1 2024.
- Arcturus Therapeutics Holdings' Gains from Investment Securities' 5-year high stood at $30.7 million during Q2 2022, with a 5-year trough of -$4.3 million in Q3 2021.
- Its 3-year average for Gains from Investment Securities is $6.3 million, with a median of $1.6 million in 2024.
- In the last 5 years, Arcturus Therapeutics Holdings' Gains from Investment Securities plummeted by 153.09% in 2021 and then skyrocketed by 645.02% in 2024.
- Arcturus Therapeutics Holdings' Gains from Investment Securities (Quarterly) stood at $21.2 million in 2020, then slumped by 71.37% to $6.1 million in 2021, then crashed by 129.87% to $30.7 million in 2022, then rose by 8.06% to $4.8 million in 2023, then crashed by 88.25% to $564,000 in 2024.
- Its last three reported values are $564,000 in Q4 2024, $2.7 million for Q1 2024, and $4.8 million during Q4 2023.